KPX Lifescience.Co.Ltd (114450) — Financial Flexibility Index
KPX Lifescience.Co.Ltd (114450) has a Financial Flexibility Index of 0.24x as of September 2025. Free cash flow of ₩3.61 Billion (operating CF ₩3.33 Billion minus capex ₩275.98 Million) represents 0% of total liabilities (₩15.22 Billion). Check KPX Lifescience.Co.Ltd (114450) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
KPX Lifescience.Co.Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for KPX Lifescience.Co.Ltd across 11 annual periods. For the full cash flow conversion analysis, see KPX Lifescience.Co.Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for KPX Lifescience.Co.Ltd. Explore KPX Lifescience.Co.Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | ₩988.20 Million | ₩525.49 Million | ₩9.22 Billion | ▼ -0.2% |
| 2023 | 0.11x | ₩845.04 Million | ₩370.02 Million | ₩7.87 Billion | ▲ +134.2% |
| 2022 | -0.31x | ₩-3.07 Billion | ₩-4.55 Billion | ₩9.79 Billion | ▼ -221.4% |
| 2021 | 0.26x | ₩4.06 Billion | ₩611.38 Million | ₩15.68 Billion | ▼ -35.1% |
| 2020 | 0.40x | ₩4.57 Billion | ₩1.90 Billion | ₩11.48 Billion | ▼ -41.4% |
| 2019 | 0.68x | ₩7.84 Billion | ₩4.24 Billion | ₩11.54 Billion | ▼ -45.8% |
| 2018 | 1.25x | ₩12.87 Billion | ₩5.38 Billion | ₩10.26 Billion | ▲ +36.5% |
| 2017 | 0.92x | ₩9.99 Billion | ₩5.68 Billion | ₩10.87 Billion | ▲ +63.2% |
| 2016 | 0.56x | ₩8.67 Billion | ₩7.07 Billion | ₩15.39 Billion | ▼ -6.0% |
| 2015 | 0.60x | ₩6.14 Billion | ₩5.62 Billion | ₩10.25 Billion | ▲ +81.4% |
| 2014 | 0.33x | ₩4.92 Billion | ₩4.09 Billion | ₩14.90 Billion | — |